Described herein are pharmaceutical packaging devices which avoid oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medicines, these methods which include a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with incredibly small permeability to oxygen and c